4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Lexaria Bioscience Corp. (LEXX) operates in the Biotechnology industry and is headquartered in Kelowna, Canada with about 7 employees. Its market capitalization is roughly $16 million. In the fiscal year ended 2025-08-31, LEXX reported $1M in revenue and ($12M) in net income.
Lexaria Bioscience Corp. operates as a biotechnology company.
Interactive charts & full statements → Open the LEXX valuation workbench →
| Income statement | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $0M | $0M | — |
| Gross Profit | $1M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($12M) | ($6M) | ($6M) | ($7M) | — |
| Net Income | ($12M) | ($6M) | ($7M) | ($7M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 |
|---|---|---|---|---|---|---|---|
| Total Revenue | — | $0M | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | — | ($2M) | ($2M) | ($3M) | ($4M) | ($3M) | — |
| Net Income | — | ($1M) | ($2M) | ($3M) | ($4M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|---|
| Total Assets | $4M | $9M | $3M | $8M | — |
| Total Liabilities | $2M | $1M | $0M | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LEXX viewer.
About TickerBase · Data methodology & sources